Clinic
Honorhealth
Honorhealth was paid $3.33M by Medicaid between Jun 2022 and Dec 2024, across 78 billing codes. Its largest line is 87502, Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets — 22% of everything it billed.
33Billing provider infoHONORHEALTH
SURPRISE, AZ 85388
SURPRISE, AZ 85388
33aNPI1942930375assigned 06/17/2022
33bProvider typeUrgent Care Clinic/Center
28Total paid$3.33M
24GClaims75,529
24DCodes billed78
24AFirst – last monthJun 2022 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Arizona
Rank by total paid#22 of 81
Median peer was paid$312K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 10,552 | $464K | |
| 2023 | 28,917 | $1.38M | |
| 2024incomplete | 36,060 | $1.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 22% | 4,668 | 4,527 | $728K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 1,044 | 1,020 | $576K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 2,260 | 2,192 | $543K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 2,724 | 2,633 | $505K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10% | 864 | 844 | $341K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.9% | 5,678 | 5,516 | $198K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.5% | 1,247 | 1,223 | $151K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.1% | 2,189 | 2,117 | $70K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 362 | 356 | $66K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 186 | 183 | $65K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 845 | 807 | $24K |
| 87634 | <1% | 2,337 | 2,290 | $22K |
66 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 526 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,999 | $10K |
| 0352U | <1% | 137 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,447 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,670 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 272 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 62 | $1K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 14 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 32 | $596.46 |
| 80076 | <1% | 1,948 | $575.73 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $502.42 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,657 | $375.29 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,434 | $373.98 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,000 | $223.35 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 294 | $213.08 |
| 73630 | <1% | 226 | $201.17 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 255 | $143.02 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 364 | $132.37 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 60 | $99.53 |
| 84484 | <1% | 1,114 | $69.36 | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,258 | $58.06 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 767 | $45.97 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,711 | $41.79 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 272 | $39.57 |
| 81025 | <1% | 2,121 | $8.95 | |
| 73090 | 0% | 14 | $0.00 | |
| 82330 | 0% | 1,043 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 2,181 | $0.00 |
| 80047 | 0% | 2,724 | $0.00 | |
| 83880 | 0% | 108 | $0.00 | |
| 84132 | 0% | 1,032 | $0.00 | |
| 85379 | 0% | 445 | $0.00 | |
| 83605 | 0% | 348 | $0.00 | |
| 85730 | 0% | 17 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 13 | $0.00 |
| 82962 | 0% | 13 | $0.00 | |
| 96376 | 0% | 30 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | $0.00 |
| 82553 | 0% | 23 | $0.00 | |
| 82435 | 0% | 1,035 | $0.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 91 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 85 | $0.00 |
| 87040 | 0% | 20 | $0.00 | |
| 83874 | 0% | 23 | $0.00 | |
| 87077 | 0% | 28 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 176 | $0.00 |
| 73610 | 0% | 137 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 1,697 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,286 | $0.00 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 369 | $0.00 |
| 81003 | 0% | 3,312 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,287 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 0% | 1,352 | $0.00 |
| 82947 | 0% | 1,035 | $0.00 | |
| 73130 | 0% | 52 | $0.00 | |
| 82565 | 0% | 935 | $0.00 | |
| 73110 | 0% | 42 | $0.00 | |
| 84295 | 0% | 1,030 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 280 | $0.00 |
| 80306 | 0% | 14 | $0.00 | |
| 85610 | 0% | 58 | $0.00 | |
| 72100 | 0% | 13 | $0.00 | |
| 73562 | 0% | 52 | $0.00 | |
| 82977 | 0% | 13 | $0.00 | |
| 90715 | 0% | 13 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHENDRIX, JENIFER (SENIOR DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Honorhealth | Phoenix, AZ | $107.15M |
| Honorhealth | Phoenix, AZ | $65.78M |
| Honorhealth | Scottsdale, AZ | $47.05M |
| Honorhealth | Scottsdale, AZ | $23.83M |
| Honorhealth | Phoenix, AZ | $7.97M |
| Honorhealth | Scottsdale, AZ | $7.44M |
| Honorhealth | Scottsdale, AZ | $232K |
| Honorhealth | Scottsdale, AZ | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.